Heart Failure After Myocardial Infarction: Clinical Implications and Treatment

被引：163
作者：
Minicucci, Marcos F. [1 ]
Azevedo, Paula S. [1 ]
Polegato, Bertha F. [1 ]
Paiva, Sergio A. R. [1 ]
Zornoff, Leonardo A. M. [1 ]
机构：
[1] UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil
来源：
CLINICAL CARDIOLOGY | 2011年 / 34卷 / 07期
关键词：
LEFT-VENTRICULAR DYSFUNCTION; MORTALITY; MORBIDITY; CAPTOPRIL; METAANALYSIS; MANAGEMENT;
D O I：
10.1002/clc.20922
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is a frequent complication of myocardial infarction. Several factors, such as recurrent myocardial ischemia, infarct size, ventricular remodeling, stunned myocardium, mechanical complications, and hibernating myocardium influence the appearance of left ventricular systolic dysfunction after myocardial infarction. Importantly, its presence increases the risk of death by at least 3- to 4-fold. The knowledge of the mechanisms and clinical features are essential for the diagnosis and treatment of left ventricular dysfunction and heart failure after myocardial infarction. Therefore, this review will focus on the clinical implications and treatment of heart failure after myocardial infarction.
引用
收藏
页码：410 / 414
页数：5
相关论文
共 36 条
  • [1] Task force 1: The ACCF and AHA codes of conduct in human subjects research
    Adams, RJ
    Antman, EM
    Kavey, REW
    [J]. CIRCULATION, 2004, 110 (16) : 2512 - 2516
  • [2] Albert NM, 2008, CRIT CARE NURSE, V28, P20
  • [3] THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION
    AMBROSIONI, E
    BORGHI, C
    MAGNANI, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) : 80 - 85
  • [4] [Anonymous], EUR HEART J
  • [5] Levosimendan: current status and future prospects
    Archan, Sylvia
    Toller, Wolfgang
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2008, 21 (01) : 78 - 84
  • [6] BALL SG, 1993, LANCET, V342, P821
  • [7] THE INITIAL CHEST-X-RAY IN ACUTE MYOCARDIAL-INFARCTION - PREDICTION OF EARLY AND LATE MORTALITY AND SURVIVAL
    BATTLER, A
    KARLINER, JS
    HIGGINS, CB
    SLUTSKY, R
    GILPIN, EA
    FROELICHER, VF
    ROSS, J
    [J]. CIRCULATION, 1980, 61 (05) : 1004 - 1009
  • [8] Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction
    Cleland, JGF
    Torabi, A
    Khan, NK
    [J]. HEART, 2005, 91 : 7 - 13
  • [9] Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
    Dargie, HJ
    Colucci, Y
    Ford, I
    Sendon, JLL
    Remme, W
    Sharpe, N
    Blank, A
    Holcslaw, TL
    [J]. LANCET, 2001, 357 (9266) : 1385 - 1390
  • [10] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
    Dickstein, K
    Kjekshus, J
    [J]. LANCET, 2002, 360 (9335) : 752 - 760
1234